Bristol-Myers Squibb Company
Acyl sulfonamide NaV1.7 inhibitors

Abstract:

The present disclosure relates to compounds of formula I which inhibit NaV1.7, and include pharmaceutically acceptable salts, compositions comprising such compounds, and methods using and making such compounds and compositions. (I) ##STR00001##